Daniel Milano PhD

Daniel is a Senior Development Engineer in the Conjugation Development Group at ImmunoGen. He serves as the technical lead for all late-stage conjugation development activities. His primary focus has been the process characterization and validation activities surrounding ImmunoGen’s lead product candidate mirvetuximab soravtansine. Prior to joining ImmunoGen, Daniel received his Ph.D. in chemical engineering from Northeastern University.